Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 8 (NPM1P8) is a pseudogene related to the NPM1 gene, which encodes a nucleolar protein involved in a range of fundamental cellular processes including ribosome biogenesis, genomic stability, and apoptosis. However, NPM1P8 itself does not code for a functional protein and is not considered a therapeutic target, nor does it have validated roles in cellular biology, disease, drug interactions, or patient monitoring[7]. NPM1P8 is a pseudogene and typically does not encode a protein or functional RNA. It is not druggable, not considered a molecular target, and has no known clinical, biological, or pharmacological significance. If your search is for a target relevant in cancer therapy, be aware that NPM1 (not NPM1P8) is the protein-coding gene in this context, with well-established roles in hematological malignancies such as acute myeloid leukemia[1][3][5]. You may have intended to refer to NPM1 rather than NPM1P8. If so, clarification is needed to supply target details about nucleophosmin 1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 8 (NPM1P8).